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ABSTRACT

Author: Duarte-Guevara, Paula, A. MS
Institution: Purdue University
Degree Received: August 2018
Title: Development of Tools to Reduce Risk of Nosocomial and Foodborne Pathogens Exposure
Major Professor: Haley F. Oliver

Transmission pathways of pathogenic bacteria are one of the most relevant fields of research
because of its direct impact not only on the public health but also on the economy. Identifying the
critical factors for bacteria spreading through the population provide new tools for the prevention
of disease and risk management. Clostridium difficile is the primary causative of antibioticassociated diarrhea in healthcare settings. C. difficile infection (CDI) symptoms range from mild
diarrhea to pseudomembranous colitis and can result in death. Awareness of the microorganism is
extremely low, and the understanding of it is far from complete. Because of this, the control,
prevention, and treatment of the disease is a challenge. It has been demonstrated that C. difficile
bacterial spores heavily contaminate surfaces, stating a clear transmission vehicle. However,
eradication of these spores from surfaces is still a challenge, mainly because there is not yet a high
market demand for this. In this project, a protocol for detection of bacterial spores from
environmental surfaces was developed. The proposed method can detect concentrations as low as
100 CFU/ml after enrichment processes. This method can be used for future studies of C. difficile
presence on hospital environments and the validation of spore eradication techniques.

In parallel, Listeria monocytogenes is one of the most relevant foodborne pathogens in the readyto-eat food industry. Despite the relatively low incidence of listeriosis cases in the population, the
mortality rate of the disease is as low as 15%, which is significantly higher when compared to
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other foodborne diseases. Several studies have focused on the risk management and prevention of
the disease; however, outbreaks are still prevalent throughout the world. Cross-contamination and
temperature abuse of the food products seem to be one of the major causatives for these outbreaks.
Here, a new time-temperature monitoring (TTM) sensor for the cold chain management is
employed to reduce the consumer exposure to mishandled and potentially contaminated products.
The demonstrated wireless sensor is capable of providing real-time data during at least two weeks.
In combination with microbial growth models, the use of the sensor will facilitate the identification
of potentially highly contaminated products before these reach the consumer.
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1. LITERATURE REVIEW

1.1 Introduction
Clostridium difficile was first described in the mid-1930s as a pathogenic anaerobe present in
newborns’ intestinal flora (Hall and O’Toole 1935). However, it wasn’t until the late 1970s when
it was identified as the primary cause of colitis when it was isolated from the feces from patients
undergoing antibiotic treatment (John G Bartlett et al. 1978). Further advances have been made in
the study of Clostridium difficile, but several aspects of the bacterium remain to be explored.

C. difficile is characterized as an obligate anaerobe, Gram-positive, rod-shaped, spore former,
pathogenic bacteria. C. difficile infection (CDI) is potentially life-threatening, especially in elderly
people. Clinical symptoms associated with CDI range from mild diarrhea to fulminant colitis.
Symptoms can include pseudomembranous colitis, toxic megacolon, bowel perforation, sepsis or
multiple organ dysfunction syndrome (Smits et al. 2016). In 2011, the CDC estimated that almost
500,000 patients had CDI with 29,000 attributable deaths in the United States (Lessa, Winston,
and McDonald 2015) Moreover, estimates for the economic burden of CDI in the United States
are over US$1 billion (Zimlichman et al. 2013).

1.1.1 Clostridium difficile toxin genes and strain classification
Strain classification is necessary to investigate the occurrence of outbreaks and to understand the
epidemiology of the disease. The primary methods used for this classification are PCR-ribotyping,
pulsed-field gel electrophoresis (PFGE), restriction endonuclease analysis (REA) and
toxinotyping. Due to the lack of systematic surveillance, no complete data is circulating on C.
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difficile before 2003. From 2003 substantial increases in the incidence and mortality rates in North
America and Europe were recorded, mainly associated with the PCR ribotype 027 and 078 (Voth
and Ballard 2005). However, these methods for classification do not have discriminatory power to
distinguish between closely related strains as is required for transmission tracking. To better
achieve this, whole genome sequencing is used to some extent although it has not been entirely
developed for C. difficile and it is not yet commonly used globally (Smits et al. 2016).

Toxin A and toxin B have been identified as the primary toxins produced by C. difficile and the
causatives of disease. The encoding genes for these toxins (tcdA and tcdB) are located in the
pathogenicity locus (PaLoc) in the bacterial chromosome (Smits et al. 2016; Voth and Ballard
2005). The PaLoc is located in the same locus of the chromosome among most strains. Toxin A is
a 308 kDa enterotoxin while toxin B is a 270 kDa cytotoxin (Rupnik, M.; Wilcox, M.H.; Gerding
2009). The complete composition of PaLoc can vary according to the strain. The most pathogenic
strains of C. difficile encode both toxin A and B and three proteins that are believed to regulate
toxin production and secretion (TcdC, TcdE, TcdR) (Awad et al. 2015).
1.1.2 Clostridium difficile infective mechanisms
C. difficile is transmitted via the fecal-oral route. Spores are highly resistant to environmental
conditions including disinfectants and antimicrobials. Therefore, spores are thought to be the
infective mechanism given that vegetative cells cannot survive in aerobic conditions. Germination
of spores is dependent on sensing primary bile acids from the liver such as taurocholate and
inhibited by secondary bile acids in the colon (Paredes-Sabja, Shen, and Sorg 2014). The
propensity of spores to colonize the intestine will depend on the gut microbiota of the host.
Antibiotic treatment can shift the gut microbiota, giving C. difficile cells opportunity to colonize
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the intestine (Theriot et al. 2016). Moreover, the presence of antibiotics like ampicillin and
clindamycin can stimulate the expression of some colonization factors by the bacterium and toxin
effects (Deneve et al. 2008).

To elicit its toxic effects, toxin A and toxin B must be internalized in the host cell through receptormediated endocytosis that requires an acidified endosome for translocation. The requirement of
low pH seems to be important for structural changes of the toxins, leading to the exposure of
hydrophobic domains before insertion into the membrane (Qa’Dan, Spyres, and Ballard 2000).
Once internalized into the cytosol, toxins inflect cell physiology and signaling; the hallmark of this
intoxication are the changes in the organization of the actin cytoskeleton of the cells. Both toxins
are defined as glycotransferases that inactivate small GTPases, targeting isoforms of Rho, Rac and
the cell division control protein 42 (Cdc42)(Voth and Ballard 2005), proteins involved in the
regulation of the cell cycle, cytoskeletal dynamics, and cell movement among others. This results
in actin condensation and consequent rounding of the cells, membrane blebbing and eventual
apoptosis of the target cells. The precise steps for the inactivation of Rho, Rac and Cdc42 proteins
by toxin A and B are not clearly understood but could include blocking membrane localization,
guanine exchange factor interaction, thus inhibiting Rho of completing its function, or contact with
downstream effectors. Particularly, tcdB exhibits a higher rate of enzymatic activity than tcdA,
leading to more rapid effects on cells (Thelestam, Florin, and Chaves-Olarte 2008).

Any strain of toxigenic C. difficile, encoding for either tcdA, tcdB or both, can cause severe lesions
through the intestine, mucosal ulceration, goblet cell loss, increased epithelial permeability,
neutrophil infiltration among others. The specific roles of tcdA and tcdB in CDI have been difficult
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to assess. Recent studies with genetic manipulation of C. difficile in mouse models have
determined that tcdB is capable of inducing phenotypes of disease in the absence of tcdA, but all
studies differ on the role of tcdA in the absence of tcdB (Carter et al. 2010). Following these
studies, a considerable number of clinical isolates express only tcdB. Strains that don't produce
either tcdA or tcdB do not result in tissue damage or disease symptoms. It has also been reported
that some epidemic strains have higher sporulation rates and that these are directly correlated with
toxin production (Hasan et al. 2011).
1.1.3 Methods for the isolation of Clostridium difficile
Since its identification as a pathogen, researchers have been interested in developing adequate
culture methods for C. difficile to further study this organism. Its resistance to antibiotics,
particularly to cycloserine and cefoxitin, was proposed to fabricate selective media (George et al.
1979). From that, cycloserine-cefoxitin-fructose agar (CCFA) was started to be used since it
allowed the selective isolation and recovery of C. difficile. Later on, the egg yolk from the original
formula was replaced with bile salt sodium taurocholate, and it was noted that the presence of this
ingredient improved the recovery of spores as well as enhanced the growth of C. difficile colonies
(Wilson, Kennedy, and Fekety 1982; Lister et al. 2014). In 2013, supplemented brain heart
infusion (BHIS) medium was proposed as a cost-effective and efficient medium for the growth,
germination, and enumeration of C. difficile (Edwards, Suárez, and McBride 2013); this method
was later adopted by the American Type Culture Collection (ATCC). On BHIS, C. difficile
colonies show a characteristic flat, irregular, ground-glass appearance. Colonies also exert a
distinctive smell, facilitating the bacteria identification. Colony confirmation is commonly done
using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF
MS) technology, latex agglutination, and toxigenic ELISA assays (Hill et al. 2013). Identification
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and confirmation techniques will be expanded in the next section.
1.2 Clostridium difficile infection (CDI) inside hospitals
1.2.1 Clostridium difficile prevalence in hospitals
CDI incidence in the United States has dramatically increased since 2000. Registered cases for
CDI increased a 2.7-fold between 2000 and 2012 based on data from Healthcare Cost Utilization
Project (HCUP) Nation Inpatient Sample (NIS) (Olsen et al. 2016). CDI was estimated to cause
as many as 14,000 deaths in 2007 and attributable mortality ranging from 5.7% in endemic settings
to 16.7% in outbreaks scenarios since 2000 (Lucado, Gould, and Elixhauser 2012). C. difficile is
now the most common cause of health-care associated infections in the U.S hospitals. Costs due
to CDI are estimated to be as much as $4.8 billion for acute care facilities alone (Magill et al.
2014). In 2011, an estimated 83,000 of the patients with CDI had at least one recurrence, and
approximately 29,000 died within 30 days after the initial diagnosis (Lessa, Winston, and
McDonald 2015).
1.2.2 Diagnostic methods
Diagnosis of CDI starts with the presence of the clinical symptoms followed by laboratory assay.
Laboratory assays can be divided into tests for C. difficile products, toxigenic culture methods, and
nucleic acid amplification methods. Current methods available for the diagnosis include cell
culture cytotoxicity assay (CCA), anaerobic toxigenic culture (TC), enzyme immunoassay (EIA)
for toxin A and B, glutamate dehydrogenase (GDH) EIA, real-time polymerase chain reaction
(PCR), MALDI-TOF, sigmoidoscopy and colonoscopy (A. Deshpande et al. 2011). Selecting the
method for detection is important to consider as identifying patients with CDI will have different
requirements than identifying asymptomatic carriers. Due to the suboptimal sensitivity of most of
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these tests, many diagnostic experts and guidelines suggest multistep algorithms where multiple
tests are used for an accurate diagnosis (Bagdasarian, Rao, and Malani 2015).

Usually, CCA and TC are the most commonly used for CDI diagnostics; therefore, these are
considered as reference tests. However, there is no real "gold standard" as these assays have low
reproducibility in combination with limited sensitivity and specificity for C. difficile. CCA has
reported a sensitivity and specificity of ~70%-100% and ~90%-100% respectively while TC has a
sensitivity of ~90%-100% and specificity of ~98%-100% (Poutanen and Simor 2004). As CCA
and TC tests are time-consuming and challenging to perform, laboratories opt for simpler and
faster assays thus sacrificing sensitivity and specificity. Molecular methods are the current trend
for diagnosis of CDI, but the FDA currently approves only four of them: BD GeneOhm assay,
Cepheid Gene Xpert assay, Illuminegene assay and Prodesse assay. These are based on the
detection by PCR of the chromosomal genes encoding for toxin B (tcdB) or the toxin regulatory
gene (tcdC) in fecal samples obtained from patients potentially infected with Clostridium difficile
(A Deshpande et al. 2013). Individually, the GeneOhm assay was pulled off the market last year.
1.2.3 CDI treatments
Since 2000 CDI treatment failures and recurrences have increased, these failures are likely related
to a complex interplay of host factors, bacterial pathogenicity and the limited ability to deliver
therapeutic levels of drug to the colon (Bagdasarian, Rao, and Malani 2015). Treatment of
asymptomatic carriers is usually not recommended since it has been demonstrated that
asymptomatic colonization does not increase the risk of symptomatic CDI and may protect against
later development of symptomatic disease (Shim et al. 1998). Metronidazole and vancomycin have
been the primary therapies for CDI since the 1980s. Early studies suggested that oral metronidazole
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and oral vancomycin had equivalent efficiencies. However, recent studies suggest that treatment
failure rates are higher when metronidazole is used in severe CDI cases (Vardakas et al. 2012).

When deciding on the treatment to use, it is essential to determine the severity of the CDI disease.
Diarrhea characterizes mild to moderate disease without systemic signs of infection and its usually
associated with antibiotic use, previous or longer periods of hospitalization, use of proton pump
inhibitors (PPI), chemotherapy, chronic disease and presence of a feeding tube. Severe CDI occurs
when systemic signs of infection appear with a low white blood cell count, associated risk factors
for severe CDI are advanced age and presence of particular strains. Complicated CDI relates with
all the risk factors previously listed plus recent surgery, history of inflammatory bowel disease
(IBD) and intravenous immunoglobulin disease; complicated CDI expresses with systemic signs
of infection including hypotension, ileus or megacolon. Recurrent CDI is more common in older
patients and those with coexistent antibiotic use, recurrences are usually associated with an
impaired immune response to C. difficile toxins and disruption of the colonic microbiota. A case
is considered as recurrent CDI when symptoms reappear within eight weeks of completing
treatment for CDI. The change of recurrence is 15-25% after treatment of an initial episode and
40-65% for patients with more than one previous recurrences (Smits et al. 2016).

Oral metronidazole remains the preferred therapy for mild to moderate CDI because of its low cost
(Debast et al. 2014). For patients unable to receive the oral treatment, metronidazole can be
administered intravenously although it is not recommended to use metronidazole as monotherapy
when delivered this way (Surawicz et al. 2013). When treating severe or complicated CDI
vancomycin therapy is preferred (Bagdasarian, Rao, and Malani 2015) in the presence of ileus,

8
vancomycin can be administered rectally as adjunctive therapy. When the CDI is recurrent, oral
metronidazole or vancomycin are recommended for first recurrences, and only vancomycin is
suggested for further recurrences. Fidaxomicin was approved for treating CDI in 2011, randomized
trials have suggested non-inferiority of fidaxomicin (87.7% success) when compared with
vancomycin (86.8% success), it was also suggested that fidaxomicin may preserve the human gut
microbiota better than alternative treatments however, this is not considered first-line therapy
because of its higher costs (Debast et al. 2014).

Preserving gut microbial diversity becomes essential when preventing recurrences. Hence,
alternative treatments are being developed. Fecal microbiota transplantation restores gut
microbiota diversity through the installation of the donor stool into the gastrointestinal tract of a
patient with CDI (Bagdasarian, Rao, and Malani 2015). This procedure has had good clinical
responses reporting an 87% clinical success rate (Cammarota, Ianiro, and Gasbarrini 2014) and
even higher when combined with vancomycin treatment. A recent feasibility study used frozen
fecal capsules from prescreened donors to treat patients with recurrent CDI resulted in a 90%
response rate after 1 or 2 treatment courses (Youngster et al. 2014). Despite these results, the FDA
still considers fecal microbiota transplantation investigational, requiring further studies to be able
to administrate to patients regularly. It has also been suggested that the use of probiotics as a
method to restore healthy gut microbiota may prevent initial episodes as well as recurrence;
however this treatment is poorly defined (Goldstein et al. 2017). Lastly, antibiotic withdrawal has
been in some cases a stand-alone treatment for mild CDI but whether antibiotic withdrawal is
effective for CDI remains unclear (J G Bartlett 1984).

9
1.2.4 Clostridium difficile transmission in hospitals
Carriers of C. difficile shed spores through their skin and feces, stating a vehicle for contamination
and transmission of the bacteria (Smits et al. 2016; Voth and Ballard 2005). In 1989 it was reported
that 49% of the rooms occupied by symptomatic patients with C. difficile were contaminated and
29% of rooms occupied by asymptomatic patients were also contaminated (McFarland et al. 1989).
Since then, many other studies have demonstrated widespread environmental contamination with
C. difficile in the rooms of patients with CDI ranging between from 2.9% and 75% (Weber et al.
2010). Most commonly, spores are found on the bedside table, the bedrail, the toilet floor and on
the patient’s call button (Sjöberg et al. 2014). C. difficile spores are also isolated from surfaces in
rooms of patients not colonized or infected with the bacteria, although with lower frequency
(Weber et al. 2010; Dubberke et al. 2005). During a CDI outbreak in North America, a study of
environmental transmission showed that 23% of the surfaces outside the patient room were
contaminated with toxin-producing C. difficile. These surfaces included computers, portable
medical equipment, and desktops. The environmental isolates genotype matched with the genotype
obtained from the stool samples from the CDI patients treated in the same unit (Dumford et al.
2009). C. difficile spores have been isolated from the air, and aerosol dissemination of the spores
may play a part in the widespread of environmental contamination (Weber et al. 2010).

C. difficile is often isolated from the hands of healthcare workers (HCW). Spores mainly
contaminate multiple skin sites including groin, chest, abdomen, forearms, and hands of patients
with CDI and can be easily transmitted with contact of those sites (Bobulsky et al. 2008). Thus,
HCW can easily acquire spores in their hands after caring for or examining patients, becoming a
transmission vehicle between patients (McFarland et al. 1989; K. H. Kim et al. 1981). It has been
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documented that, when exposed to patients with CDI, C. difficile spores are recovered from 24%
samples from HCW hands in range of one to six CFUs per hand, with the highest numbers found
following high risk care (i.e. patient washing and diaper care) (Landelle, Verachten, Legrand,
Girou, Barbut, Brun-Buisson, et al. 2014). The frequency of positive personnel hand culture has
been shown to be strongly correlated with the intensity of environmental contamination (Samore
1996; Mutters et al. 2009).
1.2.5 Environmental contamination within hospitals
Very few studies have been done on C. difficile environmental contamination outside the patient
room. In one of these, environmental contamination within a clinical laundry facility was studied
(Michael et al. 2016). This facility was responsible for processing the linens for six different
hospitals and 30 local outpatient clinics, every week 300.000 lbs. of laundry were processed.
Results showed that 24% of the samples were positive for C. difficile, of these, 64% of the isolates
were toxin positive (Michael et al. 2016). Limitations of this study included inherently poor
recovery of microbes from environmental surfaces, difficulty in culturing C. difficile spores and
differences in incubation times and media used (Claro, Daniels, and Humphreys 2014).

Food as a potential source of C. difficile among hospitalized patients was evaluated in one hospital.
In this study, food served to the patients was frozen to be later cultured. Only 0.2% of the samples
collected tested positive for the bacteria, each one with a count of fewer than 10 CFUs per ml
(Kwon et al. 2016). The fact that this study was performed in a single center and that non-specific
data about the incidence of CDI in that setting is presented may be considered as relevant
limitations. Moreover, recovery methods for C. difficile from food samples are still ambiguous and
not thoroughly developed. A similar study analyzing food as a potential source of contamination
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in a Belgian nursing house found that only 1% of the analyzed samples tested positive for C.
difficile (Rodriguez et al. 2015). Again, this study presents broad limitations as poor sampling and
culturing techniques for food samples plus a small sample size.

It is now widely accepted that environmental contamination plays an important role in the
transmission of C. difficile. The frequency of C. difficile acquisition has been linked with the level
of environmental contamination (Fawley and Wilcox 2001). Patients admitted to a room
previously occupied with C. difficile have a higher risk for CDI acquisition (Shaughnessy et al.
2011). Several studies have demonstrated that the appropriate use of gloves can prevent
transmission of C. difficile and reduce the incidence of CDI (Johnson et al. 1990) HCW should
don gloves as soon as entering the patient room. However, HCW hand contamination has been
recorded despite the use of gloves (Landelle, Verachten, Legrand, Girou, Barbut, Brun-Buisson,
et al. 2014). Surface cleaning with 70% ethanol, detergent, bleach plus mechanical force have been
registered as successful in decreasing surface contamination (Guerrero et al. 2017; Sjöberg et al.
2014) however, there is no defined protocol or product to achieve the complete decontamination
of surfaces.
1.3 Community-associated CDI (CA-CDI)
1.3.1 Clostridium difficile prevalence in community settings
As mentioned before, Clostridium difficile was traditionally considered a primary nosocomial
pathogen. However, emerging data from the last 20 years has highlighted a drastic shift in the
known epidemiology of CDI, with disease developing outside of hospitals and healthcare settings
and causing severe disease in populations that were considered to be at low risk (Bloomfield and
Riley 2016). In early 2007 the CDC recommended different case definitions for CDI. In these, a

12
community associated CDI (CA-CDI) is defined as a case with symptom onset in the community
or 48 hours or less after admission to a health care facility, provided that the symptom onset was
more than 12 weeks after that the last discharge from a health care facility (McDonald et al. 2007).
Approximately 32% of CDI cases can be classified as CA-CDI, over 27% of these are hospitalized
within the seven days after diagnosis, and the recurrence rate is 9% (Lessa 2013).

The increase in the prevalence of CA-CDI creates a pressing need to identify the characteristics of
these cases and develop knowledge about the potential risk factors for CA-CDI. However,
developing a complete epidemiological study for CA-CDI can be complicated due to the probable
underreporting and the fact that the data provided by health care facilities is only representative
for the cases that were detected in a healthcare facility and were severe enough to be treated in a
hospital, undoubtedly skewing the data. Also, the reported incidence of CA-CDI seems to vary
based on the study population and local awareness and testing practices (Bloomfield and Riley
2016).
1.3.2 Community-associated CDI (CA-CDI) risk factors
Currently, there are several established risk factors for CA-CDI. Unlike the traditional healthcareassociated CDI, CA-CDI is often documented in populations with the absence of the traditional
risk factors. Moreover, the susceptibility to infection somewhat appears to vary on a case-by-case
basis (Juneau et al. 2013). Although this is not uniform for all antimicrobials, antibiotic exposure
is the most important risk for all CDI, including CA-CDI (Kutty et al. 2010). Certain classes (e.g.,
clindamycin, fluroquinolones, and cephalosporins) present the most significant risk against others
(e.g., tetracyclines) that had no associated increased risk (Abhishek Deshpande et al. 2013).
Although a significant risk factor, some international studies have shown large proportions (43-
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65%) of CA-CDI cases had no previous antibiotic exposure (Collins et al. 2014; McFarland et al.
2007). Thus, antibiotics may play an important but non-essential role in CDI acquisition,
something that health care providers must be aware of. The use of gastric acid suppressants and
proton pump inhibitors (PPI) have also been associated with CDI, indicating that any disruption
of the microbiota may be sufficient to create susceptibility for CDI without the necessary presence
of antimicrobials (Dial et al. 2006; Dial et al. 2005).

The presence of co-morbidities is considered one of the risk factors for CA-CDI. Populations with
inflammatory bowel disease (IBD) show a high incidence, severe disease and evidence of
increasing rates over time. CDI acquisition patterns for IBD patients seem to be different from the
general population, including increased susceptibility to a wider scope of sources in the community
(Cojocariu et al. 2015). Other comorbidities such as kidney disease, immunodeficiency, malignant
lesions and solid organ transplants increase the risk of CDI because of the prolonged use of
antimicrobials and frequent contact with health care facilities (Bloomfield and Riley 2016).

As mentioned before, the first isolation of C. difficile was from the stool of healthy infants, since
then, it has been long established that the bacteria is widely present in neonates and infants younger
than 2 years, many of which do not develop any symptoms, therefore, contact with this population
is recognized as one of the risk factors (Hall and O’Toole 1935). Risk factors for the development
of the disease in children younger than two years old appear to diverge from the rest of the
population (Bloomfield and Riley 2016). CDI incidence is nearly the double in females than in
males, but no further hypotheses or explanation for this has been provided. Contact with children
as human reservoirs could explain this.
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1.3.3 CA-CDI transmission
Recent research efforts have focused on finding the potential transmission pathways in the
community settings. In 2010, the first transmission model for CA-CDI was published as an initial
step to develop a risk assessment for this bacterium in the community. In this, potential sources of
exposure in the community can be broadly categorized into consumption, person-to-person,
animal-to-person and environment-to-person (Otten et al. 2010).

C. difficile contamination in households seems to be relatively common, finding an overall
prevalence of 32% in household samples (Alam et al. 2014). C. difficile has been isolated from
boots and shoes, suggesting an introduction from contaminated soil from outside the home.
Presence of spores from kitchen surfaces and refrigerators also suggest a transfer from food
products (Weese et al. 2010). From this, people may expect to come into contact with C. difficile
in their home environments on a regular basis. Many reports demonstrate that C. difficile is
ubiquitous in natural settings, including soils, waterways and inevitably present in environments
where human fecal matter is treated such as wastewater treatment plants (Saif and Brazier 1996;
Levett 1986). Moreover, it is necessary to consider the treated animal effluent used to irrigate
agricultural products and animal manure used for fertilizer are other potential environmental
sources (Hensgens et al. 2012).
1.3.4 Clostridium difficile in production animals and food products
Molecular studies have demonstrated common C. difficile isolates in production animals,
companion animals and humans suggesting a possible zoonotic agent (Knetsch et al. 2014). As in
humans, many young animals are colonized by C. difficile; the bacterium has also been
documented in both healthy and diseased animals. Production (food) animals are widely studied
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group with C. difficile isolated from pigs, cattle, and poultry (Songer and Anderson 2006). It is
also necessary to take into account that production animals are often given broad-spectrum
antimicrobials mixed in with feed as a prophylactic measure, altering the gut microbiota as it does
in humans and making them susceptible for CDI (Songer 2004). Once the organism is introduced
into a herd, a large number of susceptible animals living in close quarters can rapidly become
infected. This is a significant concern for the food industry meaning potential contamination in
meat and dairy products.

From this, it is inevitable to think about the potential of C. difficile to act as a foodborne pathogen,
with several authors studying this possible scenario. In 2007, 42% of sampled retail meats tested
positive for toxigenic C. difficile all of which belonged to epidemic strains (Songer et al. 2009).
However, not all studies suggest the same outcome, from 2004 to 2009 only 9.5% of environmental
samples from manufacturing plants and food samples tested positive for C. difficile (Harvey et al.
2011). There is also a big difference with studies made in Europe with a common prevalence of
around 2.4% (Von Abercron et al. 2009). The potential contamination of vegetables has been
explored to a lesser extent, despite early evidence of these foods as a potential source (Saif and
Brazier 1996). It has also been possible to match the strains obtained from food samples to local
human CDI cases (Jöbstl et al. 2010). Such discrepancy between different studies can be due to
the different techniques, methods, and protocols used for the isolation of C. difficile from different
types of samples. C. difficile is known for its difficulty to culture and isolate, and because of the
lack of standardized methods to perform these studies, it is difficult to discriminate reliable data.
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With this, the ingestion of spores from contaminated food and subsequent infection of a susceptible
host is a plausible scenario. However, there is not enough epidemiological evidence linking the
consumption of contaminated food to increases of CA-CDI. Unlike most foodborne pathogens,
exposure to C. difficile, even in a large group of people, may not result in many or even one case
of infection. Moreover, the infection dose for C. difficile has not been established, and it is not
clear if there is a minimum infection dose required for a susceptible host (Hensgens et al. 2012).
At this point, public health implications and actions required are unclear, but if even the lowest
trace of C. difficile spore contamination represents risk of disease development, then prevention
measures must be directed towards the source of the problem, reevaluating the use of
antimicrobials in food animals and the handling and processing of meat products.
1.4 Conclusions
Despite the recent advances in the study of Clostridium difficile, CDI is still increasing
representing a significant burden not only on the economy but also in the public health. There is
not enough basic knowledge about the bacteria, reason for which different studies made are
inconclusive and unreliable. There is a need to go back to basics and understand the epidemiology
of the bacteria and the disease, the behavior of the bacteria in different environments, the molecular
and genomic characteristics, and the identification of primary sources of contamination for CDI
cases. It is necessary to create standardized methods and protocols for the detection and isolation
of the bacteria from different samples worldwide; these methods should also be developed to
achieve the higher specificity and sensibility possible. Then, it would be possible to obtain more
reliable results from investigative studies and further compare different results to build up
knowledge about C. difficile and then develop tools for the management of the bacteria. It is
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unlikely that the prevention and control of the bacteria will be achievable until the full dimensions
of the problem, both inside and outside of the healthcare settings, are fully understood.
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2. Clostridium difficile DETECTION FROM ENVIRONMENTAL
SAMPLES

2.1 Abstract
Clostridium difficile is the leading cause for hospital-acquired and antibiotic-associated diarrhea,
known as a C. difficile infection (CDI). Reported CDI cases have been steadily increasing since
2000, reaching costs of US$ 1 billion annually. It has been demonstrated that surface
contamination with bacterial spores participates in the cross-transmission of the disease,
particularly in hospitals and long-term health care facilities settings. However, there is not yet a
method to address this difficulty or even to clearly identify contaminated surfaces. Here, we
present a new detection protocol for C. difficile spores from environmental surfaces. The presented
protocol is based on molecular detection assays, enrichment steps, and isolation procedures,
achieving high sensitivity and specificity with minimal hands-on work. This protocol can be used
for the accurate detection of C. difficile spores on different environmental surfaces; and, therefore,
raise awareness and find solutions for the transmission of C. difficile through environmental
surfaces.
2.2 Introduction
CDI is one of the primary causes for hospital acquired diseases, causing antibiotic-associated
diarrhea and pseudomembranous colitis. C. difficile is considered to be a major nosocomial
enteropathogen, responsible for 15-25% of diarrhea cases in health care facilities (Landelle,
Verachten, Legrand, Girou, Barbut, Brun-Buisson, et al. 2014). The main established risk factors
for CDI are receipt of antibiotic therapy, age older than 65 years old, severity of underlying disease,
length of hospital stay, and a prior room occupant with CDI (McFarland et al. 1989; Sjöberg et al.
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2014). Almost all antimicrobials have been associated with CDI, including cephalosporins,
penicilllins and fluoroquinones (Poutanen and Simor 2004). The incidence of health-care
associated CDI by hospital is in the range of 4.2-131.8 per 10,000 discharges and 0.6-18.5 per
10,000 patient days (Smits et al. 2016).

The disease caused by CDI is not directly caused by vegetative cells but by the toxins produced
by the vegetative cells. Toxin A is a potent enterotoxin and toxin B is classified as a cytotoxin, in
the absence of both these toxins the bacteria won’t cause any disease (Voth and Ballard 2005).
Therefore, the presence of toxin A and toxin B are the primary markers for the diagnosis of CDI
and are commonly detected in the stools of patients by antibody-based or cytotoxicity assays.
Recently, molecular assays have been used for the diagnosis of CDIs. In these assays, real-time
PCR (qPCR) detects the chromosomal genes encoding toxins (tcdA and tcdB) directly from stool
samples. Currently, there are only 3 commercial assays available for the diagnosis of CDI by
molecular methods: Prodesse assay, Cepheid Gene Xpert assay and Illuminigene assays. All these
come in closed platforms, making them unsuitable for the detection of C. difficile from samples of
other nature.

C. difficile is transmitted via the fecal-oral route. Vegetative cells are obligate anaerobes and can
only survive a couple of minutes in the open environment. On the other hand, C. difficile spores
are highly resistant to environmental conditions (Paredes-Sabja, Shen, and Sorg 2014), including
some disinfectants and antimicrobials, because of this, spores are thought to be the vehicle for
transmission between patients.

20
Previous studies have demonstrated that C. difficile spores can contaminate various surfaces of the
hospital environment, especially when in proximity to a CDI patient (Ricciardi et al. 2012; Sethi
et al. 2017; Bobulsky et al. 2008). Surface contamination has also been associated with crosstransmission of the spores (Otten et al. 2010), a subject of particular interest in hospitals, an
environment where most of the population is in susceptibility for the disease. Inactivation and
eradication of C. difficile spores is still a challenge, with several techniques being investigated but
none of these properly validated by demonstrating and quantifying bacteria spore killing.
Hydrogen peroxide vapor, UV radiation, gaseous plasma system and sporicidal disinfectants are
among the investigated techniques (Claro, Daniels, and Humphreys 2014).

Different techniques for the detection of C. difficile spores from environmental samples have been
documented (Claro, Daniels, and Humphreys 2014; Dubberke et al. 2007; Mutters et al. 2009).
However, all of these studies have variable results, and there is not yet a specific protocol or
technique to use when sampling the environment for C. difficile spores. In this study, a new method
for the detection of C. difficile spores from environmental surfaces is presented. This method uses
sponge swabs for sampling, enrichment steps to increase pathogen concentration, qPCR for toxin
genes detection and isolation by spread plating.
2.3 Methods
Isolates. A panel of 8 different C. difficile strains, representing each one of the known toxinotypes,
was acquired from the ATCC (ATCCÒ MP-4Ô). An extra strain was obtained from the Purdue
University veterinary department to test the assay with as many strains as possible. The
experiments were performed with each strain to demonstrate the inclusivity of the assay. In Table
1 the known characteristics and classifications for the used strains are presented.
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Table 1. Used C. difficile strains and their classifications.
ATCC
isolate

C. difficile strain
designation

Toxins
profile

Toxinotype

BAA-1804

-

A+ B+

0

053

Clinical isolate

BAA-1870

4118

A+ B+

IIIb

027

Clinical isolate

BAA-1803

-

A+ B+

IIIc

027

Clinical isolate

BAA-1801

3232

A- B-

tcdA-, tcdB-

010

Human feces-adult with diarrhea

BAA-1875

5325

A+ B+

V

078

Clinical isolate

43598

1470

A- B+

VIII

017

Human feces-asymptomatic neonate

BAA-1812

-

A+ B+

XII

024

Clinical isolate

BAA-1814

-

A+ B+

XXII

251

Clinical isolate

43255

10463

A+ B+

0

087

Clinical isolate

Ribotype

Isolation source

Spore preparation: To obtain spores from the frozen stock cultures, BHIS (ATCC 1293) with
taurocholate acid agar plates were streaked several times and in different directions with the frozen
culture. Plates were then sealed with parafilm and incubated at 36°C under anaerobic conditions
for 96 hours. After the incubation period, 2ml of phosphate buffer saline (PBS) were added into
each plate and the surface of the agar was gently scraped with a cell scraper to dislodge the growth.
The dislodged culture containing spores, vegetative cells and cell fragments was collected using a
sterile pipette and pooled into a 1.5ml sterile micro centrifuge tube. The obtained solution was then
centrifuged for 10 minutes at 12 rpm, washed with PBS, heat shocked for 10 minutes at 95°C and
stored under refrigeration conditions for further use.

Enrichment experiments. Confirmation of the success of the enrichment was done by directly
inoculating the sponge with pure spore solutions beforehand. Enrichment was done with different
volumes (10ml, 15ml and 25ml) of BHIS with taurocholic acid (Sigma-Aldrich, St. Louis, MO).
Samples were then pummeled for 1 minute at 260 rpm using a stomacher, and then anaerobically
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incubated for 96 hours at 36°C. To visualize the results, 100µl of the media was plated on BHIS
before and after the incubation. Total plate count was done after 48 hours of incubation at 36°C.

Surface sampling experiments. World Bioproducts EZ Reach sponge samplers moistened with
10ml HiCap neutralizing broth were chosen to perform the surface sampling. These were chosen
based upon the good recovery rates for microorganisms, the possibility to enrich and incubate the
samples in anaerobic conditions, and the versatility of the sponge to sample surfaces of different
characteristics. Sampling was done by swabbing the sponge over a plastic tray surface following
the manufacturer’s instructions. To test the efficacy of the surface sampling with the sponge,
surfaces were artificially inoculated with 100µl of spore solutions in concentrations ranging from
100 CFU/ml to 108 CFU/ml. Spores were spread over the surface and left to dry for 1 hour, later
on, the sampling-enrichment procedure was followed as previously described.

qPCR template preparation: After the sample incubation period, at least 1ml of enriched media
was obtained from the sponge. The obtained media was centrifuged for 10 minutes at 12rpm and
re-suspended in 1ml of PBS. After vortexing, the sample was heat shocked at 95°C for 10 minutes
and then centrifuged once again for 10 minutes at 12rpm. The solution generated was used as the
template for C. difficile detection.

Toxin genes amplification. Detection was based on the amplification of tcdA and tcdB genes by
multiplexed qPCR. Using the IDT PrimerQuest Tool, primers were designed in-house to target for
the most conserved region of the toxin genes among C. difficile strains, according to literature
(Kato et al. 1991; Lemee et al. 2004; Goldenberg et al. 2010; Koo et al. 2014; H. Kim et al. 2017).
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Primers for tcdA gave and amplicon of 132 bp while primers for tcdB gave an amplicon of 120 bp.
TaqMan fluorescent probes were designed along with the primers to visualize the amplification of
DNA. HEX (excitation 538, emission 555) dye was added to the tcdA gene probe and FAM
(excitation 470, emission 520) dye was added to the tcdB gene probe. IDT OligoAnalyzer 3.1 was
used to analyze the primer sequences for possible hairpin structures, self-dimer and primer dimers.
The specific sequences and characteristics of the elements used in the qPCR reaction are presented
in Table 2. Primers and probes were manufactured by IDT DNA technologies (Skokie, IL).
Table 2. Sequences of used primers and probes for tcdA and tcdB amplification
Target

tcdA

tcdB

Fwd Primer

CAGCTACTGGTTGGGTAACTATT

GACTGTAGGCGATGATAAATACTACT

Rev Primer

CTCCTATCTGAGGTAAACCATTTCT

CCTGTTTGTAACACTCCACTTTG

Probe
Amplicon
size

CGAGCCTAATACAGCTATGGGTGCG

TGGTGGAGCTGCTTCAATTGGAGA

132bp

120bp

Extracted DNA amplification. Before performing qPCR detection methods after sampling and
enrichment, the molecular assay was first tested with DNA extracted from pure cultures. C. difficile
colonies grown in BHIS plates were dislodged using a cell scraper and contents were collected
with PBS in a microcentrifuge tube. Obtained solutions were centrifuged during 10 minutes at
12rpm and the pellet was then resuspended in PBS. After resuspension, the sample was lysed
during 10 minutes at 95°C, sample was centrifuged once again during 10 minutes at 12 rpm.
Obtained extracted DNA solution was used as template for PCR reactions. Traditional PCR with
agarose gel electrophoresis was completed for both multiplexed reactions and single gene
amplification reactions. PCR was also performed with Listeria monocytogenes extracted DNA as
a template to test the ability of the test to exclude non-target organisms. After confirmation with
PCR and gel electrophoresis, the same procedure was followed with qPCR and TaqMan probes
assay. Once the expected results for the qPCR reaction were obtained, the assay was performed
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with serial dilutions of C. difficile extracted DNA, ranging from 100 CFU/ml to 108 CFU/ml, to
determine the sensitivity of the assay. Threshold for the curves was automatically defined by the
QuantStudio thermocycler (Thermo Fisher Scientific, Waltham, MA), each dye used set a different
target for the equipment, therefore, two different thresholds were given, one per target.
Amplification curves were analyzed based on the amplification cycle (Ct) value of each curve.
Each sample was analyzed in triplicates to determine the standard deviation within amplification
cycles.

Isolating methods. Samples detected as positive were plated by spread-plating 100µl of the tested
solution on BHIS agar plates, sealed with parafilm, inversed, and incubated anaerobically at
36°C for 96 hours. Colonies were observed and confirmed based on their characteristics.
2.4 Results and Discussion
2.4.1 qPCR assay can exclusively detect tcdA and tcdB genes in a multiplexed reaction
Although the specific roles of toxins A and B in the development of CDI have been difficult to
assess, several studies have identified toxin B as the primary causative of disease, being capable
of causing severe CDI symptoms even in the absence of toxin A (Smits et al. 2016). On the other
hand, the precise role of toxin A in disease has not been clearly stated. In some studies, C. difficile
producing only toxin A (tcdA+, tcdB-) caused mild tissue damage confined to a mild oedema,
however, other reports state that C. difficile with the same toxin profile can still cause severe
disease (G.P., J.I., and D. 2010). This shows the lack of understanding of the pathogenesis of the
bacteria and enhances the importance of identifying the presence or absence of both toxins when
detecting C. difficile.
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At the same time, when creating a detection method from samples of any nature, it is crucial that
the assay is capable of discriminating between the target bacteria and background bacteria. In the
case of health care facilities, it has been reported that surfaces are not only widely contaminated
with C. difficile spores but also with L. monocytogenes, methicillin-resistant Staphylococcus
aureus (MRSA), Acinetobacter spp. among others (Weber et al. 2010). Therefore, it is necessary
to create a reliable assay that will provide specific results targeting only C. difficile.

DNA amplification of both toxin genes was successfully achieved using the in-house designed
primers. Results of the PCR and gel electrophoresis are shown in Fig 1. Toxin A gene (tcdA) had
an amplicon of 132 bp while toxin B gene (tcdB) presented an amplicon of 120 bp. Due to the
similarity of the amplicon sizes, it was not possible to observe two different bands in the agarose
gel electrophoresis for the multiplexed reaction. Negative controls for the single gene PCR and
multiplexed reactions showed no amplification as expected. When using template DNA from L.
monocytogenes for a multiplexed reaction no amplification was visualized, representing the ability
of the assay to exclude non-target organisms.

When performing the same procedure with qPCR, similar results were observed (Fig. 2). Toxin
genes show amplification around the 13th cycle, negative controls show no amplification and L.
monocytogenes show no amplification. A detailed analysis for the qPCR amplification curves is
presented on Table 3.
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Figure 1. PCR results for tcdA and tcdB amplification. Ladder (L), positive and negative controls for single tcdA gene
amplification (A+, A-), positive and negative controls for single tcdB gene amplification (B+. B-), positive and
negative control for multiplexed reaction (M+, M-) and amplification results with L. monocytogenes template (Lm)

Figure 2. qPCR results for toxin gene amplification. Positive and negative control for single tcdA amplification (PosA,
NegA), positive and negative controls for single tcdB amplification (PosB, NegB), positive and negative control for
multiplexed reaction for tcdA (PosMA, NegMA), positive and negative control for multiplexed reaction tcdB (PosMB,
NegMB) and amplification results with L. monocytogenes template for tcdA gene (LMA) and tcdB gene (LMB).

27
Table 3. Detailed amplification cycle (Ct) information for each triplicate of each sample and standard deviation
(StDev) between within each sample

Sample
PosA
NegA

r1
15.1
NA

Ct
r2
15.4
NA

StDev
r2
15.8
NA

0.351
NA

PosB
NegB
PosMA
NegMA

14.3
NA
16.9
NA

14.9
NA
16
NA

14.2
NA
16.2
NA

0.379
NA
0.473
NA

PosMB
Neg MB
LMB
LMA

13.2
NA
NA
NA

13.9
NA
NA
NA

14.1
NA
NA
NA

0.473
NA
NA
NA

2.4.2 The presented molecular assay has great inclusivity and can detect
concentrations as low as 100 CFU/ml
The infectious dose is of particular interest when talking about human pathogens, this information
is necessary to determine the risk of disease under different scenarios. This has not been established
for C. difficile, and it is not clear if there is a minimum infectious dose required for a susceptible
host (Hensgens et al. 2012). Therefore, even low levels of contamination may be sufficient to cause
disease, and studies that used methods with lower sensitivity may have under-reported prevalence
data. This, in combination with the probable low concentration of spores on surfaces, creates a
pressing need to create and use methods with exceptional sensitivity. Therefore, special attention
was set into creating a molecular assay with a low limit detection.

To determine the limit of detection of the assay, serial dilutions of the bacteria were used for the
completion of the protocol. This process was repeated with every C. difficile strain. The results for
the qPCR for both toxins detection with these dilutions are shown in Fig 3 and 4, detailed
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information for these results are presented on tables 4 and 5. According to this, the DNA
amplification test can detect concentrations as low as 100 CFU/ml.

Figure 3. qPCR amplification plot for tcdA gene from C. difficile serial dilutions.

Table 4. Detailed data for tcdA amplification cycle (Ct) from C. difficile template serial dilutions with replicates and
standard deviation (StDev)

Sample

Ct

StDev

1E+02
1E+03
1E+04

r1
32.4
30
26.8

r2
32.2
30.5
27

r2
32.7
29.2
26.3

0.252
0.656
0.361

1E+05
1E+06
1E+07
1E+08

23.5
19.5
15.9
13.2

23.8
19.2
15.8
13.5

23.1
19.8
15.3
13.7

0.351
0.300
0.321
0.252
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Figure 4. qPCR amplification plot for tcdB gene from C. difficile serial dilutions.
Table 5. Detailed data for tcdB amplification cycle (Ct) from C. difficile template serial dilutions with replicates and
standard deviation (StDev)

Sample
1E+02
1E+03
1E+04
1E+05
1E+06
1E+07

r1
30.7
30.1
26.3
23.8
19.2
15.2

Ct
r2
30.6
29.9
26.9
23.1
19.7
15.9

StDev
r2
30.3
30.8
26.6
23
19.5
16.2

0.208
0.473
0.300
0.436
0.252
0.513

1E+08

13.4

13.8

13.7

0.208

Specific data for the amplification cycles from the serial dilutions of every strain is presented in
Table 6 and 7. The assay is also capable of determining the absence of one or both toxins. When
analyzing qPCR results, all amplification after the 37th cycle should be considered as negative.
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Table 6. tcdA gene amplification cycle (Ct) for different inoculum concentrations of C. difficile of each strain along
with the present toxins in the strain.

Strain
1804
1870
1803
1801
1875
43598
1812
1814
43255
a
b

Toxin a
A+B+
A+B+
A+B+
A-BA+B+
A-B+
A+B+
A+B+
A+B+

1.E+08 b
15.6
15.9
15.7
39.2
14.9
36.7
15.2
15.8
14.2

1.E+07
17.8
18.9
18.03
NA
16.4
38.3
18.5
17.4
17.3

1.E+06
21.9
21.4
21.2
NA
19.6
39.8
21.4
22.9
20.5

1.E+05
26.1
25.4
24.2
NA
22.5
N/A
26.3
25.1
24.1

1.E+04
27.2
28.2
28.7
NA
26.9
N/A
30.3
28.3
27.2

1.E+03
31.4
33.1
31.5
NA
32.2
N/A
32.7
33.4
31.3

1.E+02
35.9
35.3
34.9
NA
35.5
N/A
36.7
36.5
34.8

Toxin profile of the selected strain
Amplification cycle for the selected spore inoculum concentration

Table 7. tcdB gene amplification cycle (Ct) for different inoculum concentrations of C. difficile of each strain along
with the present toxins in the strain.

Strain
1804
1870
1803
1801
1875
43598
1812
1814
43255
a
b

Toxin a
A+B+
A+B+
A+B+
A-BA+B+
A-B+
A+B+
A+B+
A+B+

1.E+08 b
13.7
15.1
14.3
38.9
14.3
12.8
13.9
14.7
12.3

1.E+07
16.3
17.7
17.4
N/A
15.8
15.9
17.2
16.8
15.3

1.E+06
19.3
20.9
20.3
N/A
18.9
19.2
20.1
22.3
18.6

1.E+05
24.9
23.7
22.3
N/A
21.6
22.7
24.9
26.1
22.6

1.E+04
26.9
27.1
26.9
N/A
24.5
26.1
29.7
28.4
26

1.E+03
30.2
31.1
29.7
N/A
31.1
29
30.9
32.4
29.2

1.E+02
34.2
33.3
32.1
N/A
34.7
32.7
34.8
36.3
32.2

Toxin profile of the selected strain
Amplification cycle for the selected spore inoculum concentration

2.4.3 Sample enrichment significantly increased the bacteria concentration of the
surface samples.
Contaminated environmental surfaces are being increasingly recognized as an important source
for transmission of health-care-associated pathogens, among these, C. difficile. In most cases these
spores belong to epidemic strains, particularly the toxinotype V (Dubberke et al. 2007). Health
care workers (HCW) hands have also been found to be important carriers of spores, in
concentrations ranging from one to six CFU/ml (Landelle, Verachten, Legrand, Girou, Barbut, and
Buisson 2014) spreading the bacteria beyond the patient room. Several initiatives have been taken
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to reduce the spore load in both hospital environments and on HCW hands. These include active
interventions aiming to improve cleaning practices and HCW training to reduce contamination.
After housekeeping cleaning, despite the use of bleach, it has been noted that 90% of the surfaces
remain contaminated with C. difficile spores, creating a pressing need to generate new or improved
cleaning practices for hospital environments (Guerrero et al. 2013). Alternatively, appropriate use
of gloves by HCW can prevent transmission and reduce the incidence of CDIs (Johnson et al.
1990).

Although these initiatives and practices do not completely eradicate all spore contamination from
surfaces, there is still the possibility that these practices reduce the spore concentrations on
surfaces. In this case, a new challenge for detection of bacteria arise due to the low number of
microorganisms present during the sampling. Despite their fast speed, direct detection methods
have very high limits of detection, causing the risk of false negative results. Several studies have
been trying to identify the best methods and materials for this purpose. Different selective media
has been analyzed (Hill et al. 2013), and culture methods have been compared, noting that a
combination of initial broth enrichment would increase the recovery of C. difficile (Hink,
Burnham, and Dubberke 2013; Lister et al. 2014). Fecal samples of patients with CDI are highly
contaminated with C. difficile spores, with concentrations up to 108 CFU/g (Smits et al. 2016)
therefore, molecular diagnostic assays do not have the necessity of an enrichment step, giving
these assays a high limit of detection and making them not suitable for detection of spores from
non-clinical samples.
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To increase bacteria concentration and likelihood of detection from the environmental sample, an
enrichment step was added into the protocol. BHIS with taurocholate acid was used to enrich the
sample. Different volumes (10ml, 15ml and 25ml) of media were tested for the enrichment step
with 100 CFU/ml inoculum on the sponge. As it is possible to see on Fig. 5 the best recovery rate
was accomplished by enriching the sample with 10ml of BHIS. Incubation of the enrichment was
done under anaerobic conditions at 96 hours at 36°C. In Fig. 5 a comparison between spread
plating of the sample before and after enrichment is presented, it is evident that the enrichment
process is successful, showing a significant increase of colonies in the enriched sample.

Figure 5. Recovery of C. difficile after enrichment with different media volumes. From right to left: 25ml, 15ml and
10ml.
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Figure 6. BHIS agar plates cultured before and after enrichment.

It is also possible to see the success of the enrichment process in the qPCR assay where an enriched
sample will show amplification in a lower cycle than the non-enriched sample (Fig 7). This is due
to the higher concentration of bacteria in the template used for both qPCR reactions. A detailed
analysis of the amplification growth curves is presented in table 8.

Figure 7. qPCR amplification plot for multiplexed reaction. Positive control (PosA, PosB), after enrichment (Enriched
A, Enriched B), before enrichment (ColonyA, ColonyB) and negative control (NegA, NegB)
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Table 8. Amplification cycle (Ct) for samples before and after enrichment for three replicates per sample with
standard deviation (StDev)

Sample
PosA
PosB
EnrichedA
EnrichedB
ColonyA
ColonyB
NegA
NegB

r1
14.1
13.5
18.7
16.2
23.2
22.9
NA
NA

Ct
r2
14.5
13.1
18.2
16.4
23.7
23.3
NA
NA

StDev
r2
13.8
13.9
18.6
16.9
23.9
23.7
NA
NA

0.351
0.400
0.265
0.361
0.361
0.400
NA
NA

2.4.4 The complete presented protocol takes under one week and requires minimal
hands-on work
A summary of the complete detection and isolation protocol is presented on Fig 8. The complete
process can take up to six days if looking to harvest spores from the sample, or four days if working
only with vegetative cells. The hands-on work during this process may take up to four hours total
during the entire process. It is also possible to get some preliminary results if plating directly before
the enrichment process, this would only take around 48 hours, however, sensitivity is compromised
when taking this approach.

Figure 8. Protocol summary

When evaluating pathogen-specific rapid molecular assays both quantitative analytical data and
logical reasoning is used to determine whether the given assay is likely to perform is needed
(Wiedmann et al. 2014). Although the inclusivity and sensitivity of the present assay performed
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well, there were several limitations for this study that will need further testing and experimenting.
The most relevant limitation is the lack of evaluation of the assay with naturally contaminated
surfaces; this could have some repercussions in both the sensitivity and specificity of the assay,
because of the presence of a wider variety of background bacteria. Even though the assay showed
no false positives when working with L. monocytogenes, the specificity of the assay needs to be
further tested since, as mentioned before, a wider presence of bacteria is expected when testing
hospital environmental samples. Moreover, the reproducibility of the assay could not be assessed,
since all the experiments and protocols were performed by the same personnel, in the same
settings, and with the same equipment. There is a lack of knowledge on how variation on these
will affect the obtained results. However, repeatability of the assay was good, presenting consistent
results throughout the experiments. Importantly, the presented assay is compatible with standard,
economic media available to be prepared in the laboratory without any special equipment,
something that is not common when working with C. difficile. The lack of understanding and
study of this bacteria is worrisome, there are still several questions on the basic characteristics of
the bacteria that, if not resolved, will stall the development of control and prevention techniques
for this serious disease.
2.5 Conclusion
Despite the evident importance of surface contamination, good cleaning practices, and spore
eradication from surfaces, there is not yet a validated method to clearly identify the actual
contamination on surfaces or the effectiveness of different eradication and cleaning practices.
Studies aiming to demonstrate or analyze these aspects use in-house developed protocols without
studying the effectiveness, sensitivity, or specificity of these. Therefore, data in this area is very
sparse, leaving a lot of unresolved questions and raising some new ones.
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To resolve this issue there is the need to create a validated protocol capable of detecting C. difficile
spores from different environmental surfaces, with a good demonstrated sensitivity and specificity.
In this study a new protocol is presented for the detection and isolation of C. difficile from
environmental samples. The presented protocol does not require a great amount of time on handson work, presents great inclusivity, sensitivity and specificity, and the ability to identify the
presence or absence of toxins A and B individually. This protocol can be used for sampling
surfaces of different nature, from patient rooms to waiting rooms and dining areas. If using a
standardized protocol for the detection of C. difficile from environmental surfaces, the obtained
data will be reliable and comparable between each other, providing tools for understanding the
transmission methods of the bacteria, improving environmental cleaning practices and developing
prevention measures for the bacterial transmission trough surfaces.
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3. DEVELOPMENT OF WIRELESS TIME-TEMPERATURE
MONITORING (TTM) SENSORS TO IDENTIFY TEMPERATUREABUSE CONDITIONS IN PRODUCTS THAT SUPPORT GROWTH
OF Listeria monocytogenes.

3.1 Abstract
Temperature abuse of food products during distribution and retail is a significant challenge for
food safety management systems. For ready-to-eat (RTE) foods this represents an increased
concern because of the likeliness of these products to act as a vehicle for the transmission of
foodborne diseases. Temperature control of RTE food products during their entire life cycle is
essential for safety and quality from farm to fork. Several tools have been created for this purpose,
but most of these present relevant drawbacks such as low-resolution temperature data, short life
cycle, or high costs. Here, we demonstrate the application of a user-friendly, wireless timetemperature sensor capable of transmitting real-time data for at least two weeks (Duarte-Guevara
et al. 2018). In association with growth models of pathogens on different retail products, this device
has the potential not only to create a control tool for the management of food products but also to
predict storage conditions that allow or accelerate pathogen growth if present in the product.
3.2 Introduction
A cold chain is defined as constant temperature control during the transport and storage system of
refrigerated goods between suppliers and consumers, with the purpose of maintaining the quality
and safety of food products (Montanari 2008). Any temperature abuse or unexpected changes in
the cold chain can lead to compromised food safety and food quality, that ultimately can result in
increased food waste and increased burden of food-associated disease. The importance of an
appropriate cold chain management has been widely studied since 2002, and it has been noted that
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interruption of the cold chain can have repercussions over the quality of the product, the customer
trust over the brand, the public health, and can also bring relevant economic losses (Ndraha et al.
2018).

Ready-to-eat foods (RTE) are of particular concern because of their extensive processing
procedures, long storage time, and consumption without any thermal treatment. In 2015 it was
demonstrated that cross-contamination of deli meats is extremely likely to happen in retail
delicatessens and that one crucial step to prevent foodborne diseases is temperature control
(Pouillot et al. 2015). It has also been noted that appropriate temperature control in delicatessens
can have a more significant impact on the safety of the products than sanitation practices and
worker behavior (Gallagher et al. 2016). Listeria monocytogenes is an organism of particular
attention in these scenarios, due to its capacity to adapt to environmental conditions and grow
under refrigeration temperatures (Walker, Archer, and Banks 1990). Maintaining deli products at
a temperature recommended by the FDA Food Code can prevent a significant proportion of
additional risk linked to L. monocytogenes growth in retail (Gallagher et al. 2016).

Despite the evident importance of this subject, temperature control and cold chain management in
manufacturing and retail scenarios is still a challenge. According to the FDA, refrigerated food
products should always be kept under temperatures equal to or lower than 4°C. However, in an
FDA retail risk factor study in 2008, 60% of the retail delis studied were not holding the
recommended temperature for products. Moreover, 70% of the refrigeration cases in bakeries, pork
butcher, and dairy product retailers exceed 7°C (Morelli et al. 2012). Also, 42% of ham products
are kept over 4°C, and the temperature of pasteurized milk fluctuates from 3.9°C to 10.9°C during
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transportation through Greece, which can be related to the transportation conditions in the United
States (Derens-Bertheau et al. 2015; Koutsoumanis and Gougouli 2015). Temperature control
problems at retail occur because of lack of compliance with temperature specifications for
refrigerated foods, poor design of cold storage facilities, and uneven temperature distribution in
fridges (Koutsoumanis and Gougouli 2015; Ndraha et al. 2018; Baldera Zubeldia et al. 2016).
During transportation, temperature deviations are also associated with the position of products and
packages in the container; the situation is worsened for refrigerated food during loading and
unloading of the cargo (Estrada-Flores and Eddy 2006; Moureh et al. 2002).

To address known and unknown temperature control challenges, time-temperature indicators
(TTIs) are starting to be introduced in food packages. The working principle of these can be based
on molecular diffusion, polymerization reactions, and enzymatic activity (Taoukis 2001). TTI can
visualize cumulatively time-temperature dependent changes that reflect the history of the food
product (Giannakourou et al. 2001). This time-temperature dependent change can be visualized as
a color change, indicating that the food product has been exposed to an inappropriate temperature
for a defined period. Although TTIs can be a useful tool for food cold chain management, the
amount and resolution of the provided data by these is not helpful when trying to estimate
microbial risk, providing only qualitative information about the storage conditions of the product.
Electronic wireless temperature-monitoring technologies are a new trend for cold chain
management. These have been favored because they can record data more accurately and more
conveniently while also reducing costs. However, several drawbacks of these tools have been
noted such as the time to load large amounts of data, the reading range, low battery life, and the
limitation of real-time delivery and sensing capability (Ahmed et al. 2015; Becker et al. 2009).
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The purpose of this on-going study is to develop a proof-of-concept wireless time-temperature
monitoring (TTM) sensor imbedded in a flexible packaging substrate capable of transmitting
detailed time-temperature histories of food products during distribution and storage. In this report,
early concept remote sensor design is described and used in combination with dynamic L.
monocytogenes growth curves created to predict the concentration of bacteria over time.
3.3 Methods
TTM sensor construction. A TTM sensor system was proposed in collaboration with the Purdue
University School of Electrical and Computer Engineering. This sensor was fabricated on a
flexible platform configuration to be easily mounted on food packages. Frequent wireless
communication with a base-station was proposed for data gathering; ability to store data and low
energy cost were the main milestones to achieve. The sensor electronics for temperature recording,
temporary storage of data, and communication with the base-station were fabricated on a doublesided printable circuit board (PCB).

TTM is achieved through capacitance change due to temperature variation; this capacitance change
is recorded through a capacitance-to-digital module. Gathered data is processed, timed, and
communicated with a Nordic nRF module and then visualized on a computer. To determine the
accuracy of the measurements taken with the sensors, the response of the sensing elements to
temperature change was compared with a thermocouple response to temperature change (DuarteGuevara et al. 2018). Calibration of the capacitance measurements with temperature measurements
was then completed. Finally, the temperature measurements of the microbiological incubator, the
measurements of a thermocouple, and the measurements of the sensors were compared.
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Growth curves elaboration. L. monocytogenes 10403S growth in retail RTE meats was measured
under isothermal and dynamic temperature conditions. Portions of 25 grams of RTE deli meat
were inoculated with 104 CFU/ml of L. monocytogenes 10403S and incubated under different
temperature profiles ranging from 3°C to 14°C for 300 h. These profiles were created with the
intention of imitating the conditions that food products may be exposed to during transportation
or in a deli case and were classified based on the total amount of time the product was exposed to
temperatures out of compliance (>4°C), from what is generally suggested to keep the safety of
food products. The total amount of time the products were exposed to temperatures out of
compliance ranged between 100 and 200 hours.

Bacteria concentrations on the product were determined at different times based on the used
temperature profiles with more frequent sampling with exposure to higher temperatures. After
incubation, 50 ml of PALCAM (Millipore Sigma, Burlington, MA) broth was added to 25g of deli
meat inoculated with L. monocytogenes 10403S. The sample was then pummeled in a stomacher
for one minute at 260 rpm, and 100 µl of the obtained solution was plated in triplicates on
PALCAM agar, dilutions were made if necessary. Plates were incubated for 24 hours at 36°C, and
colonies were counted. Calculation of the initial concentration was done with the obtained data,
and the construction of growth curves in comparison with the used temperature profile was
completed. Ham, salami, and turkey are the most consumed deli meats in the United States;
therefore, we performed these experiments with each one of those products. Furthermore, to
analyze the growth behavior of the bacteria in the presence and the absence of microbial growth
inhibitors (GI), experiments were done on ham, turkey, and salami with and without GI.
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Statistical analysis. A preliminary equation (1) was generated to visualize better the possible
associations affecting the L. monocytogenes growth kinetics under different temperature profiles
on RTE deli meats.
!"Œ$% &Œ$' œá
*+"Œ$% &Œ$' œá

(1)

In this equation, C represents the horizontal asymptote the bacteria concentration reaches at
approximately 109 CFU/ml, b0 represents the inherent exponential growth of the bacteria, and b1c
represents the growth based on the temperature function. To start testing this equation and for
further development, it was necessary to determine b1c, which represents the bacterial growth in
function of the temperature. With this purpose in mind, the relationship between the area of the
temperature curve above 5°C and bacteria concentration increase was established, using R studio
(RStudio Inc, Boston, MA) for data analysis. This method was called "degree days" in which,
according to the number of temperature degrees over 5°C the product was exposed to and the
period this exposure occurred, a determinate increase of the bacterial concentration was achieved.
This was determined based on the information from the growth curves on all products, with and
without growth inhibitors.
3.4 Results and Discussion
3.4.1 The employed TTM sensor is capable of providing detailed time-temperature
data in real time during at least two weeks.
Effective cold chain management for maintaining the safety of food products should rely on the
prevention through monitoring, recording and controlling of critical parameters during the entire
product’s life cycle, including post-processing and extending to the time of consumption
(Koutsoumanis and Gougouli 2015). It is clear that temperature plays a crucial role in food safety
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management; however, temperature control is still a challenge. Several devices for temperature
management are currently available in the market. One example of these is the 3M MonitorMarkÒ
(3M Co., St Paul, Minnesota) (Menske, 1976), a diffusion-based indicator label that relies on the
color change of an oxidable chemical system, controlled by temperature-dependent permeation
through a film. Although useful for short-term temperature management, devices like this have
low resolution, do not offer detailed information about the conditions the product has been exposed
to, cannot provide information during the entire lifecycle of the product plus personnel needs to
physically acquire the data given by the device, increasing the labor necessary for the use of these
TTIs. Therefore, new and innovative tools for the surveillance of this should be developed and
accessible to the market.

The constructed TTM sensor by the Prof. Peroulis’ team at the Purdue School of Electrical and
Computer Engineering provided detailed time-temperature data in real time for over two weeks
and stored data during interrupted connections with the base station (Duarte-Guevara et al. 2018).
As seen in Fig.9, the three sensing elements were connected to the PCB through a flexible ribbon
cable ideal for the integration of the sensor into food packages. The sensing elements and the PCB
were covered with a pharmaceutical-grade epoxy layer to make it resistant to humidity and
environmental conditions. The total length of the sensor used was 10 cm with 4 cm of width, with
a reading range of 10 meters, and capability of storing data for at least two weeks. Capacitance
response to temperature changes exhibited an inverse linear response when compared to the
thermocouple measurements. When calibrated to temperature measurements, capacitance changes
showed a linear response to temperature variation.
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Figure 9. Wireless time-temperature sensor fabricated and developed by the School of Electrical and Computer
Engineering (Prof. Peroulis’ team)

Software used for the sensor was developed along with the sensor by the School of Electrical and
Computer Engineering. From the computer base station, the timing between measurements was
programmed to be between 1 second and 30 minutes. The sensor also could increase or decrease
this timing, based on the acquired temperatures, taking measurements more frequently as the
temperature increases. As seen in Fig. 10, besides providing the real-time measurements, the
software of the device also presents real-time graphing of the obtained data and different
visualization options (Duarte-Guevara et al. 2018). It also was able to determine if the temperature
of the product complied with the established requirements, setting warning signals if it is not.
Moreover, several sensors can be connected and collecting data at the same time, providing tools
for a large-scale monitoring. The presented software is remarkably user-friendly, opening fields
for the application of the system in a wide variety of settings and along different steps of the retailconsumer chain.
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Figure 10. Screenshot of the software for the time-temperature sensor. Raw data acquired, real-time data plotting and
general status of the product temperature.

3.4.2 Even with only short periods of exposure to increased temperatures, L.
monocytogenes can reach high concentrations in food products with and without
growth inhibitors.
L. monocytogenes growth curves were completed under constant temperature conditions
(isothermal) of 4°C, 10°C, 21°C, and 31°C. As shown in Fig. 11, L. monocytogenes can reach high
concentrations in the product under all conditions tested. The rate of bacterial growth was related
to the temperature, the higher the temperature, the less amount of time the microorganism will take
to reach high concentrations. Particularly compelling is the case where the inoculated product was
incubated at 4°C, the temperature generally recommended for the storage of RTE products. In Fig.
11 it can be observed that although the bacteria did not present relevant growth during the initial
hours, exponential growth was later presented until reaching similar final concentrations than the
ones achieved on the products stored at high temperatures. This demonstrates the ability of L.
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monocytogenes to adapt to refrigeration temperatures and grows under these conditions, once again
exhibiting the increased risk of contamination and transmission of this pathogen.

Figure 11. L monocytogenes growth over time on deli meats under isothermal conditions of 4°C, 10°C, 21°C, and 31°C.

Cross-contamination is one of the most common events in retail delis that will directly increase
the risk of listeriosis (Pouillot et al. 2015) therefore; it is necessary to explicitly explore the effect
of temperature on bacteria growth in products contaminated even with low concentrations of the
bacteria. One potential method to control L. monocytogenes in RTE products is the use of
antimicrobial agents, also named growth inhibitors (GI) such as sodium diacetate (SD), it has been
reported that a 0.5% concentration of SD present listericidal properties in turkey (Schlyter et al.
1993). Salts of organic acids such as SD are widely used in the RTE meat industry; these organic
acids can cross the cell membrane and disassociate the cytoplasm casing decrease on the
intracellular pH and affecting the cell metabolism, resulting in reduced growth (Stasiewicz,
Wiedmann, and Bergholz 2010). Since then, several organic acids such as sodium nitrate and
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sodium diacetate have been used as antimicrobial agents in food products. The formulation of RTE
products with growth inhibitors has been reported to have the most significant impact on the
predictive risk of listeriosis for the susceptible population. , and although these may not be suitable
to use on all RTE products, the level of predicted relative risk reduction provides a mitigation
option that may nearly eliminate the risk (Gallagher et al. 2016).

The multiple routes of infection of L. monocytogenes may be a contributory factor to the lack of a
single dose-response relationship for human listeriosis (McLauchlin et al. 2004). It is generally
accepted that a concentration of 106 CFU/ml is enough to cause disease, but recent reports of a
lower infectious dose have emerged. Under dynamic temperature conditions, L. monocytogenes
still reached concentrations of 106 after »300 hours. As shown in Fig. 12 and 13, these results were
similar for ham and turkey products, but on the other hand, salami did not support the growth of
L. monocytogenes over time, either under isothermal or dynamic temperature conditions. This
could be related to the low water activity of salami or the presence of other ingredients making the
product unsuitable for microbial growth. When tested on products with GI (i.e., sodium nitrate) a
slower and diminished growth of the bacteria was expected. Surprisingly, the growth curves
generated on products without GI did not have any difference against the ones made on products
with GI, creating an interrogation about the effectiveness of GI in RTE products (Fig. 12 and 13).
These results were observed under both isothermal and dynamic temperature conditions.
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Figure 12. L. monocytogenes growth under isothermal conditions (4°C) on different deli meats with and without GI.
Ham without and with GI (NH, IH), Turkey without and with GI (NT, IT) and salami with and without GI (NS, IS)

Figure 13. L. monocytogenes growth under dynamic temperature conditions on different deli meats with and without
GI. Ham without and with GI (NH, IH), Turkey without and with GI (NT, IT) and salami with and without GI (NS,
IS)
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It is necessary to create more control points to prevent the growth of microorganisms in
contaminated products. Recent prior studies have demonstrated that storage temperature
significantly affects the microbial growth rate on food products (Gallagher et al. 2016; Pouillot et
al. 2015; Vaikousi, Biliaderis, and Koutsoumanis 2009; Tsironi et al. 2016; Giannoglou et al.
2014). Here, we demonstrated that temperature abuse and disruption of the cold-chain of products,
even during short periods, can trigger the growth of L. monocytogenes on food products, creating
a risk for the consumer. It was also noted that the bacteria could also reach high concentrations,
even under constant refrigeration temperatures, demonstrating the particular attention that needs
to be taken with this microorganism.
3.4.3 There is a clear relationship between the exposure of food products to
temperatures over 5°C and the bacterial concentration
Predictive microbiology is an area of food microbiology that has been gaining an increased
significance as a tool for risk analysis and shelf life prediction. In predictive microbiology,
mathematical models are developed to estimate the growth or inactivation of microorganisms in
food (Huang 2013). To assess the growth of microorganisms, the most basic models, called
primary models, are used to describe the primary growth of the bacteria under isothermal
conditions. These models may include models such as the modified Gompertz, logistic models,
and Barayani model (Gibson, Bratchell, and Roberts 1988; Baranyi and Roberts 1995). However,
when talking about dynamic temperature conditions, a different approach needs to be taken. The
kinetic parameters of the bacteria growth under dynamic temperature conditions need to be
defined, and then these parameters need to be demarcated on the specific food product. Finally,
these factors need to be demonstrated in a mathematical equation. The visualized relationship
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between time-temperature variation and Listeria monocytogenes 10403S growth on turkey, ham,
and salami is represented in Fig. 14.

Figure 14. Degree days and cumulative CFU/ml change in ham without growth inhibitors (NH), ham with growth
inhibitors (IH), salami without growth inhibitors (NS), salami with growth inhibitors (IS), turkey without growth
inhibitors (NT) and turkey with growth inhibitors (IT)

It is possible to see that, as expected, there is a linear relationship between degree days and the
total growth of bacteria for turkey and ham. Under a Pearson test, the correlation gives a p-value
of 3.9E-5 < 0.05, demonstrating a statistically significant correlation. This relationship is not
present for L. monocytogenes growth in salami, most likely due to the product characteristics as
previously discussed. Again, the presence of growth inhibitors did not cause any difference in the
stated relationship. Based on this analysis, it is safe to say that the higher the temperature and the
longer the period this exposure happens, the more significant increase in bacteria concentration on
the food product. It is worth noting that this linear relationship was visualized when comparing the
bacteria concentration not in between sampling days but between initial and final concentrations,
meaning that the temperature and growth are not directly correlated on the day-to-day basis.
3.5 Conclusion
We present the application of a wireless sensor for the real-time transmission of time-temperature
data to a base station. The device, that was developed by the Prof. Peroulis’ team at the School of
Electrical and Computer Engineering, is also capable of storing the gathered information and can
be set up to take measurements within different intervals. Independent change of the measurement
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intervals based on the temperature detected is also possible. The software provided is user-friendly
and can be easily controlled by people that have limited knowledge of food safety, making it
possible to set up control points in transportation and storage systems. Also, due to the detailed
data provided, it is also possible to identify the time and date where the product was mishandled,
providing tools to determine the pitfalls in the food safety management system and develop plans
of actions to correct them. This device can also be used in the surveillance of the appropriate
functionality and use of deli cases and retail storage facilities, settings that have been found to be
mishandled and in non-compliance with the required standards.

When used in combination with growth models, this device will also be able to provide information
of potential pathogen content on food products, assuming the product was initially contaminated,
reducing the exposure of the consumer to foodborne pathogens and; therefore, decreasing the
incidence of food-associated disease. Food products exposed to inadequate temperatures should
be submitted to further assays for pathogen detection. This time-temperature profile will also be
useful when guaranteeing the shelf life and quality of retail products.
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